Annual FCF
-$39.53 M
-$11.10 M-39.06%
December 31, 2023
Summary
- As of February 7, 2025, ELDN annual free cash flow is -$39.53 million, with the most recent change of -$11.10 million (-39.06%) on December 31, 2023.
- During the last 3 years, ELDN annual FCF has fallen by -$24.32 million (-159.84%).
- ELDN annual FCF is now -701.44% below its all-time high of -$4.93 million, reached on December 31, 2016.
Performance
ELDN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$11.77 M
-$4.00 M-51.39%
September 30, 2024
Summary
- As of February 7, 2025, ELDN quarterly free cash flow is -$11.77 million, with the most recent change of -$4.00 million (-51.39%) on September 30, 2024.
- Over the past year, ELDN quarterly FCF has increased by +$482.00 thousand (+3.93%).
- ELDN quarterly FCF is now -255.16% below its all-time high of $7.58 million, reached on June 30, 2016.
Performance
ELDN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$37.41 M
+$482.00 K+1.27%
September 30, 2024
Summary
- As of February 7, 2025, ELDN TTM free cash flow is -$37.41 million, with the most recent change of +$482.00 thousand (+1.27%) on September 30, 2024.
- Over the past year, ELDN TTM FCF has increased by +$2.46 million (+6.17%).
- ELDN TTM FCF is now -1048.90% below its all-time high of $3.94 million, reached on March 31, 2017.
Performance
ELDN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ELDN Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.1% | +3.9% | +6.2% |
| 3 y3 years | -159.8% | +3.9% | +6.2% |
| 5 y5 years | -232.4% | +3.9% | +6.2% |
ELDN Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -39.1% | at low | -157.5% | +3.9% | -32.9% | +6.2% |
| 5 y | 5-year | -185.3% | at low | -1997.9% | +3.9% | -379.6% | +6.2% |
| alltime | all time | -701.4% | +5.4% | -255.2% | +3.9% | -1048.9% | +10.5% |
Eledon Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$11.77 M(+51.4%) | -$37.41 M(-1.3%) |
| Jun 2024 | - | -$7.77 M(-11.1%) | -$37.90 M(-1.2%) |
| Mar 2024 | - | -$8.74 M(-4.3%) | -$38.34 M(-3.0%) |
| Dec 2023 | -$39.53 M(+39.1%) | -$9.13 M(-25.5%) | -$39.53 M(-0.9%) |
| Sep 2023 | - | -$12.25 M(+49.0%) | -$39.88 M(+23.9%) |
| Jun 2023 | - | -$8.22 M(-17.2%) | -$32.20 M(+6.6%) |
| Mar 2023 | - | -$9.92 M(+4.7%) | -$30.19 M(+6.2%) |
| Dec 2022 | -$28.42 M(-1.7%) | -$9.48 M(+107.4%) | -$28.42 M(+1.0%) |
| Sep 2022 | - | -$4.57 M(-26.5%) | -$28.15 M(-8.2%) |
| Jun 2022 | - | -$6.22 M(-23.8%) | -$30.67 M(-3.9%) |
| Mar 2022 | - | -$8.16 M(-11.4%) | -$31.90 M(+10.3%) |
| Dec 2021 | -$28.91 M(+90.1%) | -$9.21 M(+29.8%) | -$28.91 M(-0.8%) |
| Sep 2021 | - | -$7.09 M(-4.7%) | -$29.14 M(+28.9%) |
| Jun 2021 | - | -$7.45 M(+44.1%) | -$22.61 M(+24.3%) |
| Mar 2021 | - | -$5.17 M(-45.2%) | -$18.18 M(+19.5%) |
| Dec 2020 | -$15.21 M(+9.8%) | -$9.43 M(+1581.5%) | -$15.21 M(+95.0%) |
| Sep 2020 | - | -$561.00 K(-81.4%) | -$7.80 M(-23.0%) |
| Jun 2020 | - | -$3.02 M(+37.5%) | -$10.13 M(-15.8%) |
| Mar 2020 | - | -$2.20 M(+8.6%) | -$12.03 M(-13.2%) |
| Dec 2019 | -$13.86 M | -$2.02 M(-30.0%) | -$13.86 M(-8.8%) |
| Sep 2019 | - | -$2.89 M(-41.3%) | -$15.19 M(-0.3%) |
| Jun 2019 | - | -$4.92 M(+22.3%) | -$15.23 M(+11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$4.02 M(+20.0%) | -$13.64 M(+14.7%) |
| Dec 2018 | -$11.89 M(-20.4%) | -$3.35 M(+14.2%) | -$11.89 M(+6.7%) |
| Sep 2018 | - | -$2.94 M(-12.0%) | -$11.15 M(-4.1%) |
| Jun 2018 | - | -$3.33 M(+46.8%) | -$11.63 M(-28.8%) |
| Mar 2018 | - | -$2.27 M(-13.0%) | -$16.33 M(+9.3%) |
| Dec 2017 | -$14.94 M(+202.9%) | -$2.61 M(-23.6%) | -$14.94 M(+9.8%) |
| Sep 2017 | - | -$3.42 M(-57.5%) | -$13.61 M(+16.6%) |
| Jun 2017 | - | -$8.03 M(+810.5%) | -$11.67 M(-396.0%) |
| Mar 2017 | - | -$882.00 K(-31.0%) | $3.94 M(-179.9%) |
| Dec 2016 | -$4.93 M(-88.2%) | -$1.28 M(-13.6%) | -$4.93 M(-61.3%) |
| Sep 2016 | - | -$1.48 M(-119.5%) | -$12.75 M(-41.2%) |
| Jun 2016 | - | $7.58 M(-177.7%) | -$21.67 M(-46.4%) |
| Mar 2016 | - | -$9.76 M(+7.3%) | -$40.41 M(-3.3%) |
| Dec 2015 | -$41.80 M(+97.7%) | -$9.09 M(-12.6%) | -$41.80 M(+6.7%) |
| Sep 2015 | - | -$10.41 M(-6.7%) | -$39.17 M(+17.9%) |
| Jun 2015 | - | -$11.15 M(+0.0%) | -$33.23 M(+20.8%) |
| Mar 2015 | - | -$11.15 M(+72.6%) | -$27.51 M(+30.1%) |
| Dec 2014 | -$21.15 M(+36.4%) | -$6.46 M(+44.5%) | -$21.15 M(+44.0%) |
| Sep 2014 | - | -$4.47 M(-17.6%) | -$14.69 M(+43.8%) |
| Jun 2014 | - | -$5.43 M(+13.3%) | -$10.21 M(+113.3%) |
| Mar 2014 | - | -$4.79 M | -$4.79 M |
| Dec 2013 | -$15.50 M(+65.9%) | - | - |
| Dec 2012 | -$9.34 M | - | - |
FAQ
- What is Eledon Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals annual FCF year-on-year change?
- What is Eledon Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals quarterly FCF year-on-year change?
- What is Eledon Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals TTM FCF year-on-year change?
What is Eledon Pharmaceuticals annual free cash flow?
The current annual FCF of ELDN is -$39.53 M
What is the all time high annual FCF for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high annual free cash flow is -$4.93 M
What is Eledon Pharmaceuticals annual FCF year-on-year change?
Over the past year, ELDN annual free cash flow has changed by -$11.10 M (-39.06%)
What is Eledon Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of ELDN is -$11.77 M
What is the all time high quarterly FCF for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high quarterly free cash flow is $7.58 M
What is Eledon Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, ELDN quarterly free cash flow has changed by +$482.00 K (+3.93%)
What is Eledon Pharmaceuticals TTM free cash flow?
The current TTM FCF of ELDN is -$37.41 M
What is the all time high TTM FCF for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high TTM free cash flow is $3.94 M
What is Eledon Pharmaceuticals TTM FCF year-on-year change?
Over the past year, ELDN TTM free cash flow has changed by +$2.46 M (+6.17%)